Email updates

Keep up to date with the latest news and content from BMC Research Notes and BioMed Central.

Open Access Short Report

Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults

Brian M Dixon1, Tyler Barker2, Toni McKinnon1, John Cuomo1, Balz Frei3, Niels Borregaard4 and Adrian F Gombart3*

Author Affiliations

1 USANA Health Sciences, Inc, 3838 West Parkway Boulevard, Salt Lake City, UT 84120, USA

2 Sport Science Department, The Orthopedic Specialty Hospital, Murray, UT 84107, USA

3 Linus Pauling Institute and Department of Biochemistry and Biophysics, Oregon State University, Corvallis, OR 97331, USA

4 The Granulocyte Research Laboratory, Department of Hematology, National University Hospital, Copenhagen, Denmark

For all author emails, please log on.

BMC Research Notes 2012, 5:575  doi:10.1186/1756-0500-5-575

Published: 24 October 2012



Transcription of the cathelicidin antimicrobial peptide (CAMP) gene is induced by binding of the bioactive form of vitamin D, 1,25-dihydroxyvitamin D, to the vitamin D receptor. Significant levels of the protein hCAP18/LL-37 are found in the blood and may protect against infection and/or sepsis. We hypothesized that serum vitamin D levels may modulate the circulating levels of hCAP18. Only three studies have shown a positive correlation between circulating 25-hydroxyvitamin D and hCAP18 levels. Here we provide additional evidence for such a correlation in healthy, middle-aged adults.


Serum levels of 25-hydroxyvitamin D [25(OH)D] and plasma levels of hCAP18 were determined in 19 healthy middle-aged (mean of 50.1 years) adult men and women. Plasma hCAP18 concentrations correlated with serum 25(OH)D concentrations in subjects with 25(OH)D levels ≤ 32 ng/ml (r = 0.81, p < 0.005) but not in subjects with concentrations > 32 ng/ml (r = 0.19, p = 0.63).


We conclude that plasma hCAP18 levels correlate with serum 25(OH)D levels in subjects with concentrations of 25(OH)D ≤ 32 ng/ml as opposed to those with concentrations > 32 ng/ml and that vitamin D status may regulate systemic levels of hCAP18/LL-37.

Vitamin D; 25-hydroxyvitamin D; Cathelicidin; hCAP18; LL-37; Immunity; Serum; Plasma; CAMP; Infection